Replies to post #186934 on Biotech Values

[exwannabe]

250 million in December 2015 would give a 3B run rate. A steady build to 250 million in December could yield only 1.8 billion for 2015.

But a linear ramp starting at 0 is unreasonable (as I assume you just calculated).

The US market will ramp fast, the EU will take time.